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Abstract
Background: Anemia early in life has been associated with delayed cognitive and motor development. The WHO
recommends home fortification using multiple micronutrient powders (MNPs) containing iron as a strategy to
address anemia in children under two. We evaluated the effects of a program freely distributing MNP sachets to
caregivers of infants in rural China.
Methods: We conducted a cluster-randomized controlled trial in Shaanxi province, enrolling all children aged
6–11 months in target villages. Following a baseline survey, investigators randomly assigned each village/
cluster to a control or treatment group. In the treatment group, caregivers were instructed to give MNPs
daily. Follow-up was after 6, 12, and 18 months of intervention. Primary outcomes were hemoglobin concentrations
and scores on the Bayley Scales of Infant Development.
Results: One thousand, eight hundred and-two eligible children and their caregivers were enrolled. At baseline 48%
(870) of children were anemic and 29% (529) were developmentally delayed. Six hundred and-ten children (117
villages) were assigned to the control group and 1192 children (234 villages) were assigned to the treatment
group. Assignment to the treatment group was associated with an improvement in hemoglobin levels (marginal
effect 1.77 g/L, 95% CI 0.017–3.520, p-value = 0.048) and cognitive development (marginal effect 2.23 points, 95%
CI 0.061–4.399, p-value = 0.044) after 6 months but not thereafter. There were no significant effects on motor
development. Zero effects after the first 6 months were not due to low compliance, low statistical power, or
changes in feeding behavior. Hemoglobin concentrations improved in both the treatment and control groups
over the course of the study; however, 22% (325) of children remained anemic at endline, and 48% (721) were
cognitively delayed.
Conclusions: Providing caregivers with MNP sachets modestly hastened improvement in hemoglobin levels that
was occurring absent intervention; however, this improvement did not translate into improved developmental
outcomes at endline.
Trial registration: ISRCTN44149146; prospectively registered on 15th April 2013.
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Background
Despite a spectacular rise in well-being in China over
the past three decades, a large number of individuals re-
main in poverty. As a result of this poverty and associ-
ated factors, under-nutrition remains stubbornly high,
particularly among children in China’s poor rural areas.
Although rates of stunting and wasting are low, a large
fraction of children in poor regions suffer from micronu-
trient deficiencies [1–3]. By far, the most common of
these is iron deficiency [4–6]. According to data from
China’s Food and Nutrition Surveillance System, anemia
rates among young children under 2 years of age in 2005
were 30–40% in poor rural areas nationally [3, 7–9].
More geographically-focused studies have shown anemia
rates higher than 50% in some areas [9–12]. Given that
there are more than 8 million children born each year in
rural areas, this implies that roughly 3 million children
under 2 years old in rural China are anemic [13]. In
China, it is postulated that 90% of anemia in infants and
young children results from iron deficiency [14].
Anemia in early childhood is known to be particularly
pernicious as it can serve to perpetuate poverty by keep-
ing children from reaching their developmental poten-
tial. In the short run, anemia and iron deficiency in the
first years of life is a major risk factor for cognitive,
physical and emotional delays [15–23]. In the longer
run, it can negatively affect educational attainment and
even reduce earnings in adulthood [24–27]. These con-
sequences may be irreversible, even if anemia is cor-
rected later in childhood [24–28].
In settings with high prevalence of anemia (>20%) among
children under 2 years of age, the WHO recommends
home fortification of foods with multiple micronutrient
powders (MNPs) [29]. This recommendation is based on a
Cochrane review of eight randomized controlled trials that
concluded MNPs to be effective in improving iron status
and reducing anemia [30]. A more recent meta-analysis in-
cluding several more recent studies also concluded that
MNPs were effective in increasing hemoglobin concentra-
tion, but also noted substantial heterogeneity in effects
across geographical settings [31]. In a recent cluster-
randomized trial in Colombia, investigators found that
MNPs were ineffective at reducing anemia or improving
cognitive outcomes [31, 32]. They attribute the lack of effi-
cacy of MNPs to the particular evolution of anemia with
age among the Colombian population (early peak at under
1 year and rapid decline thereafter) and to a declining rela-
tive contribution of iron deficiency to remaining anemia as
children age in Colombia. These characteristics of anemia
set Colombia apart from settings where MNPs have been
effective. In addition to geography, existing trials have also
varied in aspects of study design including the age of tar-
geted children, the duration of supplementation, and the
timing of endline measurements [31].
Following the recommendations of the WHO, China’s
government has announced intentions to implement a
program to distribute MNPs through local clinics in
nationally-designated poverty counties [33]. The pro-
gram has already been initiated in select areas; however,
the effectiveness of MNPs has yet to be rigorously evalu-
ated in China.
We present the results of a large-scale effectiveness
trial of home fortification using MNPs in villages in
rural western China. In line with the national program,
we designed the trial to begin providing supplements
when children were 6–11 months old and track out-
comes every 6 months over 18 months. In addition to
hemoglobin and anemia, we evaluate effects on cogni-
tive and psychomotor development measured using the
Bayley Scales of Infant Development (BSID), given the
well-established link between early childhood anemia
and cognitive and physical delays [15–23]. Such devel-
opmental delays in early childhood can have significant
consequences long term. Studies have linked early
childhood interventions to increased college attend-
ance, employment, earnings as well as reductions in
teen pregnancy and criminal activity [34–36].
Methods
Study design, sampling frame, and participants
We carried out a cluster-randomized controlled trial in
southern Shaanxi Province. Shaanxi is a relatively poor
province in Western China and ranks 19 out of 31 prov-
inces nationally in terms of wealth. To identify the sam-
ple, we first selected 174 townships from 11 nationally-
designated poverty counties in southern Shaanxi. All
townships in each county were included except (1) the
one township per county that housed the county seat
and (2) those townships that did not have any villages
with at least 800 people. These exclusion criteria were
chosen to ensure a rural sample and increase the likeli-
hood that sampled villages had a sufficient number of
children 6–11 months of age.
Within each township, sample villages were selected in
April, 2013. We used official government data to com-
pile a list of villages in each township. We then ran-
domly selected 2 villages from the list in each township.
An additional village was selected in randomly chosen
townships to meet power requirements. Our final sam-
ple consisted of 351 villages. A list of all registered births
over the past 12 months was obtained from the local
family planning official in each village. All children in
our desired age range (6–11 months) were enrolled in
the study. A second cohort of children in our desired
age range (6–11 months) was enrolled from the same
sample villages in October 2013. Overall, the baseline
sample included 1802 children.
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Following the baseline survey for the first cohort,
villages were allocated to an MNP arm or a control
arm. For the first 6 months of the study, a random
half of the MNP arm also received text message re-
minders. (Results are qualitatively similar excluding
this group – this analysis is reported in Table 6 in
Appendix.) The intervention period lasted for
18 months for both cohorts (from April 2013 to Oc-
tober 2014 for cohort 1 and from October 2013 to
April 2015 for cohort 2).
Randomization and masking
Following the baseline survey, we randomly assigned 117
villages to the control group and 234 villages to the micro-
nutrient group using computer code (in Stata version 12).
Randomization was stratified within counties.
We did not use a placebo in the control group for eth-
ical and practical reasons. Caregivers were not aware
that they were in an RCT.
Interventions
We used a Heinz-produced MNP called “NurtureMate.”
The powder is tasteless and each daily-dose sachet con-
tains 6 mg of iron as well as zinc, vitamins A, C, D, B1,
B2,B6, B12, and folic acid (Table 1). NurtureMate is rec-
ommended for infants and toddlers aged 6–36 months.
The full composition of the NurtureMate sachets was
based on the general standard for complementary food
supplements in China [37] and was approved for use in
the national program to distribute MNPs through local
clinics in poverty counties (piloting for the national pro-
gram began after the start of this study, but not in our
study regions).
Caregivers in the MNP arm were given a 6-month
supply of sachets every 6 months. At the first distribu-
tion they were also given information about the causes
and consequences of anemia along with oral and written
instructions on how to use the powder, specifically to
give one packet per day mixed with the child’s food.
During the first distribution, households were also given
a plastic storage envelope in which to store the empty
NurtureMate sachets. Thus, the treatment was designed
to include components of a policy distributing MNP sa-
chets (including information on sachets and use and
interaction every 6 months through sachet distribution).
This allows us to identify the effects of such a policy, be-
yond the impact of MNPs themselves.
Data collection
The research team conducted four rounds of data collec-
tion for each cohort. The initial baseline survey was con-
ducted in April 2013 for cohort 1 and in October 2013 for
cohort 2. During each survey round, nurses from Xi’an Jiao-
tong Medical School collected data on hemoglobin concen-
trations from all children. Hemoglobin concentrations were
Table 1 Composition of NurtureMate home fortification powdersa
Nutrients Unit Average content
per packet (1 g)
RNI or AI in China
(6–11 months)
per dayb
RNI or AI in China
(12–36 months)
per day
RNI or AI (%)
6–11 month 12–36 month
Iron (ferrous lactate) mg 6.0 10 12 60% 50%
Zinc (zinc sulfate) mg 4.80 8 9 60% 53%
Vitamin A μgRE 200 400 500 50% 40%
Vitamin C mg 50.0 50 60 100% 83%
Vitamin D μg 5.0 10 10 50% 50%
Vitamin E mg 1.55 3 4 52% 39%
Vitamin B1 mg 0.30 0.3 0.6 100% 50%
Vitamin B2 mg 0.50 0.5 0.6 100% 83%
Vitamin B6 mg 0.30 0.3 0.5 100% 60%
Vitamin B12 μg 0.5 0.5 0.9 100% 56%
Folic acid μg 66 80 150 83% 44%
Niacin mg 3.0 3 6 100% 50%
Energy kJ 15 – –
Protein g 0 – –
Fat g 0 – –
Carbohydrate g 0.9 – –
aNurtureMate can be mixed in with either water or complementary foods, such as porridge, and is recommended for children aged 6–36 months. Recommended
consumption is 5–7 sachets per week (one per day)
bRNI: Recommended Nutrient Intake. AI: Adequate Intakes
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measured using HemoCue Hb 201+ finger prick systems
(HemoCue Ltd., Ängelholm, Sweden).
Teams of enumerators collected socioeconomic data
from study households. Each child’s primary caregiver
was identified and administered a survey on child, par-
ent and household characteristics including each child’s
gender, birth order, maternal age and education. Each
child’s age was obtained from his or her birth certifi-
cate. The primary caregiver was identified by each fam-
ily as the individual most responsible for the child’s
care (typically the child’s mother or grandmother).
As part of the household survey in each round of data
collection, the primary caregiver was asked about the di-
ets of children in the household. Caregivers were asked
whether the child’s diet during the previous day included
items from each of seven food categories: meat or fish;
beans, nuts or seeds; milk products; eggs; fruits and veg-
etables rich in Vitamin A; other fruits and vegetables;
and grains. We designed questions about food consump-
tion as a series of yes/no questions to minimize meas-
urement error. Detailed questions were also asked about
breastfeeding and formula consumption.
Enumerators tallied unused and empty packets to
assess compliance in follow-up surveys. Although
there is some potential for measurement error, this
compliance measure is unlikely to be biased because
households and enumerators had little incentive to
misreport use of MNP sachets. Further, measures
based on counting empty sachets were consistent with
the count of unopened sachets and with responses
given by caregivers about sachet use.
All children were also administered the Bayley Scales of
Infant Development (BSID) Version I, an internationally-
scaled test of children’s cognitive and motor development
[38]. The BSID is widely used in research on early child-
hood development, and is often considered a “gold stand-
ard” for assessing early childhood development [39]. The
test was formally adapted to the Chinese language and en-
vironment in 1992 and scaled according to an urban
Chinese sample [40, 41]. Following other published stud-
ies that use the BSID to assess child development in China
[42–44], it was this officially adapted version of the test
that was used in this study. All BSID enumerators
attended a week-long training course on how to adminis-
ter the BSID, including a 2.5 day experiential learning pro-
gram in the field. The test was administered in the
household using a standardized set of toys and detailed
scoring sheet. The BSID takes into consideration each
child’s age in days, as well as whether he or she was pre-
mature at birth. These two factors, combined with the
child’s performance on a series of tasks using the stan-
dardized toy kit, contribute to the establishment of the
two sub-indices: MDI, which evaluates memory, habita-
tion, problem solving, early number concepts,
generalization, classification, vocalization and language to
produce a measure of cognitive development; and PDI,
which evaluates gross motor skills (rolling, crawling and
creeping, sitting and standing, walking, running and jump-
ing) and fine motor skills to produce a measure of psycho-
motor development [45]. For the analysis, raw scores for
each of these sub-indices are normalized using the distri-
bution of scores in a reference group of healthy children
in China of the same age supplied by the testing company.
These normalized scores have an expected mean of 100
and a standard deviation of 16, with impairment for each
index defined as a score below 80.
Statistical analysis
We analytically calculated the sample size for the study
to detect a 0.2 standardized effect on MDI scores. Based
on previous studies [41, 46–49], we assumed an
intracluster correlation of 0.1 and that baseline scores
would account for 50% of the variation in scores at end-
line. We further assumed that there would be four sam-
ple children per village after attrition. Based on these
parameters, we calculated that we required 112 villages/
group to detect a standardized effect of 0.2 at 80% power
given a significance level of 0.05. We added five villages
to each group to overpower the study and to account for
potential attrition as funding allowed.
The primary outcomes of the study were hemoglobin
(measured in g/L) and the two subindices of the BSID:
the MDI and PDI. We also report effects on anemia
(using the WHO definition of altitude-adjusted Hb con-
centration below 110 g/L) [50] for comparability with
existing lieterature, but note that there is uncertainty
over the appropriateness of hemoglobin thresholds to
define anemia status [51].
We estimated the treatment effects on our primary
outcomes using intent-to-treat (ITT) analysis. We used
multiple regression analysis to estimate ITT impacts.
When estimating effects on hemoglobin concentration,
we adjust for child gender and age and also control for
Hb test machine fixed effects. When estimating effects
on BSID scores, we control for child gender, age, care-
giver engagement (playing/singing yesterday) and BSID
tester (enumerator) fixed effects. All regressions control
for cohort fixed effects and county (strata) fixed effects
to account for the randomization procedure. In all ana-
lyses, we account for clustering within villages (the level
of randomization) using Huber-White cluster-adjusted
standard errors.
In order to accommodate partial compliance and to
estimate the effect of MNP sachet use on hemoglobin
concentrations and development scores, we use an in-
strumental variables approach to estimate the average
treatment on the treated effect [52]. Specifically, we in-
strument the total number of sachets consumed (as of
Luo et al. BMC Public Health  (2017) 17:738 Page 4 of 16
each survey round) with a variable indicating whether
the child was assigned to the MNP group (the instru-
mental variable). This allows us to estimate the causal
effect of MNP sachet consumption, assuming a linear
relationship.
In order to aid in the interpretation of effects on the
primary outcomes of the study (hemoglobin and BSID
scores), we also assess impacts of the MNP intervention
on feeding behavior. The MNP intervention may cause
caregivers to feed children more nutritious foods if, for
example, the intervention increased awareness of or at-
tention to nutrition generally. On the other hand, it
could also “crowd-out” more nutritious foods if MNPs
are viewed by caregivers as a substitute for food sources
of micronutrients. For each of the seven food categories,
we estimate the ITT effects in the same manner as with
the primary outcomes, but controlling only for cohort
and county fixed effects.
Statistical analyses were conducted using STATA 13.0
(StataCorp, College Station, TX, USA). P-values below
0.05 are considered statistically significant.
Results
A total of 1834 children were enrolled at baseline
across the two cohorts (Fig. 1). We excluded 32 chil-
dren due to serious illnesses. Table 2 shows
Second round 
follow-up (Apr. 
2014 for cohort 1 
and Oct. 2014 for 
cohort 2)
All 1834 children aged 6-11 
months in 174 towns and 351 
villages
Baseline (958 children
(Cohort 1) enrolled in
Apr. 2013 and 876 
children (Cohort 2) 
32 children
excluded due 
to serious 
illness
(Congenital
heart disease
etc.)
351 villages randomly assigned to 
trial arms 
334 villages allocated to MNP 
Group, 1192 children in 
sample (629 in cohort 1 and 
563 in cohort 2)
Allocation 
(Apr. 2013)
117 villages allocated to 
Control Group, 610 children
in sample (313 in cohort 1 
and 297 in cohort 2)
First round 
follow-up (Oct. 
2013 for cohort 1 
and Apr. 2014 for 
cohort 2)
70 lost to 
follow up 
1052 children in 
follow-up after 6 
months
540 children in 
follow-up after 6 
months
106 lost to follow-up
93 re-engaged from 
baseline
1039 children in 
follow-up after 
12 months
140 lost to 
follow up 
48 lost to follow-up
54 re-engaged from 
baseline
546 children in 
follow-up after 
12 months
Endline survey 
(Oct. 2014 for 
cohort 1 and Apr. 
2015 for cohort 2)
975 children in 
follow-up after 
18 months
132 lost to 
follow-up
68 re-engaged
515 children in 
follow-up after 
18 months
60 lost to 
follow-up
29 re-engaged
enrolled in Oct. 2014)
Fig. 1 Trial profile. MNP = Micronutrient Powder
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characteristics of children included in the analysis
sample at baseline. Of the 1802 children, 1592 (88%)
remained in the sample at 12–17 months of age,
1585 (88%) remained in the sample at 18–23 months
of age, and 1490 (82%) remained in the sample at
24–29 months of age. No villages (clusters) were lost.
Attrition rates did not vary significantly between the
experimental arms (Table 7 in Appendix).
At baseline, the average hemoglobin concentration
of 6–11 month olds was 109 g/L. Nearly half of the
sample children (49%) were anemic. Fourteen percent
of children were delayed in their cognitive develop-
ment (MDI score < 80) and 24% of children were
delayed in their psychomotor development (PDI
score < 80); 29% of children had either cognitive or
psychomotor delay.
The average number of sachets consumed each month
in the MNP group over the course of the study was 14
(SD 11.6—Table 8 in Appendix). The average number of
sachets consumed declined slightly across the survey
waves from 16 sachets per month in the first 6-month
period to 13 sachets in the third.
Figure 2 shows the average hemoglobin concentra-
tion (Panel A) and anemia prevalence (Panel B) with
95% confidence intervals over the four survey rounds,
separately for the MNP and control group. Overall,
Table 2 Baseline characteristics by experimental arm (N = 1802)
Characteristics Control Group
(n = 610)
Free MNP Group1
(n = 1192)
P2
Social economic status
Age in months3 9.46 ± 1.90 9.50 ± 1.83 0.75
Girls (%) 49.0 (299) 46.5 (544) 0.26
Low birth weight (%) 4.4 (27) 4.7 (56) 0.80
First birth (%) 62.3 (380) 62.7 (747) 0.88
Families received social security support (%) 24.4 (149) 23.2 (276) 0.45
Caregiver and mother characteristics
Mother is primary caregiver (%) 79.2 (483) 81.8 (975) 0.31
Maternal education ≥9 years (%) 78.4 (478) 82.3 (981) 0.07
Maternal age (year) 26.2 ± 4.3 26.5 ± 4.7 0.25
Child feeding practices
Ever breastfed (%) 87.7 (535) 89.3 (1064) 0.36
Exclusive or predominant breastfeeding <6 Months (%) 37.7 (230) 37.8 (451) 0.97
Still breastfed ≥12 Months (%) 39.2 (239) 37.3 (444) 0.14
Ever formula-fed (%) 63.4 (387) 66.4 (792) 0.07
Supplementary feeding after six months (%) 65.9 (402) 65.3 (778) 0.87
Parenting practices
Played with baby yesterday with toys (%) 49.8 (304) 46.7 (557) 0.12
Sang song to baby yesterday (%) 29.0 (177) 28.7 (342) 0.78
Child nutrition status
Hemoglobin concentration (g/L) 4 109.3 ± 13.0 109.1 ± 12.5 0.71
Anemia prevalence (%)4 49.3 (297) 48.5 (573) 0.88
Child development status
MDI test score5 97.2 ± 17.0 96.6 ± 16.9 0.87
PDI test score6 90.1 ± 18.0 90.1 ± 16.7 0.85
Data are presented as mean ± SD or % (n) for categorical variables
1MNP = Multiple Micronutrient Powder
2 P-values from tests of the null hypothesis of no difference between MNP and control groups, adjusted for cohort and county fixed effects and clustering
within villages
3 Data missing for 4 children in the free MNP group
4Data missing for 7 children in control group and 10 in the free MNP group
5Data missing for 1 child in control group and 4 in the free MNP group
6Data missing for 2 children in control group and 5 in the free MNP group
7Data missing for 4 children in control group and 2 in the free MNP group
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there is a steady increase in hemoglobin levels (and a
steady decrease in anemia rates) over the course of
the study in both groups. In the control group, aver-
age hemoglobin rose from 109 g/L on average when
children were 6–11 months old to 118 g/L when
children were 24–29 months old. Corresponding
anemia rates more than halved, but remained high
(23%).
Trends in the MDI (Panel C) and PDI (Panel D) indi-
ces also are presented in Fig. 2. Over the course of the
study there was a marked decline in average MDI scores
from 97 to 81. The number of children with cognitive
delay increased from 14% at 6–11 months of age to 49%
at 24–29 months of age. In contrast to MDI, we find
that average PDI scores increased over time, rising from
90 to 102.
Table 3 shows the estimated treatment effects of the
MNP intervention on hemoglobin concentration, anemia
status and the two BSID sub-indices based on the ITT
analysis. For each outcome, we report impact estimates
at 6, 12, and 18 months after the start of the
intervention.
The effect of the MNP intervention on average
hemoglobin concentration was 1.77 g/L (p = 0.048; 95%
CI 0.02—3.52 g/L) after 6 months (when children were
12 to 17 months of age). This effect did not persist, how-
ever. At 12 and 18 months after the start of the inter-
vention, estimated effects are not statistically different
from zero. After 6 months of the intervention, we find a
reduction in anemia of six percentage points (18%);
however, this does not reach statistical significance at
5%. We find no effect on anemia status after 12 or
18 months of intervention.
The effect of the MNP intervention on cognition (MDI)
shows a pattern similar to that of hemoglobin concentration.
After 6 months of supplementation, the effect of MNP con-
sumption on the MDI sub-index was 2.23 points (p = 0.044;
95% CI 0.061—4.399), equal to 0.13 SD of the baseline dis-
tribution in the control group. We did not detect a signifi-
cant effect on MDI after 12 or 18 months (p > 0.5). We did
A B
C D
Fig. 2 Hemoglobin concentration (g/L), anemia prevalence (%), mental and psychomotor Development of sample children by experimental arm and
age/survey wave. MNP = Multiple Micronutrient Powders, MDI = Bayley Mental Development Index, PDI = Bayley Psychomotor Development Index
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not detect any significant effect on PDI scores in any of the
time periods. No significant harms were reported.
We find no significant effects for any time period
when estimating effects on the probability of delay (MDI
or PDI < 80) rather than the continuous MDI and PDI
measures. These results are reported in Tables 9 and 10
in Appendix.
Table 4 reports the effects of MNP consumption es-
timated using instrumental variables (IV) in order to
account for imperfect compliance. We estimate that
each additional sachet consumed during the first
6 months of the program increased hemoglobin con-
centration by 0.023 g/L (p = 0.04; 95% CI
0.001—0.045). This estimate suggests that with full
compliance (the recommended one sachet per day),
MNPs increased hemoglobin concentration by 4.14 g/
L (180 days × 0.023 g/L) assuming a linear relation-
ship. The implied increase is 2.07 g/L with 50% com-
pliance. Similar to the ITT estimates, however, we do
not find a significant effect of MNPs on hemoglobin
concentrations after 12 or 18 months even after
adjusting for compliance. The analysis does not find
any significant effects on anemia prevalence in any of
the time periods after the baseline.
For MDI, the IV analysis suggests that each additional
sachet consumed increased MDI by 0.028 points
(p = 0.034; 95% CI 0.002—0.054) at 6 months. By
12 months after the start of the intervention, however,
this effect also subsided. The analysis did not detect any
effects on MDI at 12 or 18 months. We did not detect
any significant effect on PDI scores in any of the time
periods.
Results for feeding behavior are presented in Table 5.
At baseline (when children were 6–11 months of
age), we find that few children in either group were
fed iron rich foods such as meat (around 18% were
fed meat or fish) or legumes (around 18% report
feeding beans, nuts and seeds). Most children were
fed grains (approximately 86%), milk products
(around 58%), and fruits and vegetables rich in Vita-
min A (around 55%) the previous day. Eggs were fed
to around 34% of children and other fruits and vege-
tables were fed to 48% of children.
How feeding practices transition as children age is also
evident in Table 5. Focusing on the responses of care-
givers in the control group across the four survey waves,
three patterns are of particular note. First, a dramatic
overall change in diet occurs between when children are
6–11 months to when they are 12–17 months of age.
There is a significant increase in the consumption of all
food categories. This is not unexpected as this is a time
when solid foods are introduced.
Second, there is an initial increase followed by a level-
ing off of consumption of grains, eggs, and fruits and
vegetables. Nearly all children are consuming grains by
12–17 months. Around 45% of children are consuming
eggs by 12–17 months. The consumption of fruits and
vegetables is increasing until children are 18–23 months.
By this time around 80% of children were fed vegetables
or fruits rich in Vitamin A the previous day and around
70% had been fed other fruits and vegetables.
Finally, there is a gradual increase across the four
waves in the consumption of iron-rich foods (meat and
fish; beans, nuts and seeds). However, by 24–29 months
consumption of beans, nuts and seeds remains below
50% and the consumption of meat and fish remains
below 60%.
These patterns are largely consistent across both the
control and intervention groups; in other words, we do
not find that the intervention had important effects on
feeding behavior. Although children in the intervention
group consume significantly higher quantities both of
vegetables and fruits rich in Vitamin A at 12–17 months,
and of milk products at 24–29 months, there are few
significant differences overall. There is no evidence that
the intervention crowded out nutritious foods.
Discussion and conclusion
In a large-scale cluster randomized trial of multiple
micronutrient powders (MNPs) in rural China, we
found that home fortification using MNPs signifi-
cantly increased hemoglobin levels after 6 months of
supplementation (when children were 12 to 17 months
of age) but that hemoglobin levels were not signifi-
cantly higher than the control group after 12 months
of supplementation (when children were 18 to
23 months of age) or after 18 months of supplemen-
tation (when children were 24 to 29 months of age).
During this period from 6 to 30 months of age, a
time in which children’s diets are in transition,
hemoglobin concentrations in the control group in-
creased rapidly (although anemia levels remained
high). The MNP intervention hastened this improve-
ment during the first 6 months, however, these posi-
tive effects subsided thereafter as hemoglobin levels
accelerated absent intervention as children aged from
12 to 17 months to 18–23 months of age.
The effects of the intervention on cognition (as
measured by MDI scores on the BSID) followed a
similar pattern of effects over time to that observed
on hemoglobin concentration. We found a significant
improvement on the MDI score at 6 months. How-
ever–although it would be reasonable to hypothesize
a sustained or delayed effect of supplementation on
cognitive development even after MNPs no longer af-
fected hemoglobin–cognitive scores were also not sig-
nificantly higher than the control group after 12 or
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18 months of supplementation. MNPs had no detect-
able effect on motor development at any point during
the trial.
Using an IV analysis to adjust for partial compliance,
we find a similar pattern of results, suggesting that the
lack of effects in later rounds was not due to reduced
consumption of the MNP sachets. Moreover, nil effects
after the 6 month mark were unlikely due to low power.
The study retained power to detect small effects
throughout the trial as evidenced by relatively tight con-
fidence intervals on impact estimates in later rounds.
Although it is difficult to say what led to this lack of ef-
fects, we note that our results are strikingly similar to those
of a recent trial testing MNPs in Colombia [31, 32]. The au-
thors of the Colombia study suggest that the zero/low ef-
fects in that study may have been due to the changing
nature of the causes of low hemoglobin and rapidly de-
creasing anemia rates over time as children (in the control
group) age. As with our study, they find that hemoglobin
concentrations in the control group increased substantially
as children aged from 12 to 30 months. This is in contrast
to less rapid increases in hemoglobin concentration (absent
intervention) in other regions where trials of MNPs have
been successful [53, 54]. We find no evidence that the
MNP intervention changed food consumption suggesting
that the lack of observed effects is not due to a crowding-
out of nutritious foods.
Another possibility is that the amount of iron in the
sachets used in this study (6 mg) was simply too low.
Most previous trials of MNPs used sachets that con-
tained 12.5 mg of iron [30, 31]. The amount of iron in
the sachets was set at 6 mg in order to comply with reg-
ulations in China [37]. Sachets with similarly low iron
content have been suggested for use in a national pro-
gram distributing sachets through local health centers.
One major difference between this study and the
proposed national program is that the national pro-
gram would provide MNP sachets through local
health centers while we delivered sachets to the
homes of caregivers. The average effect of the na-
tional program is therefore likely to be smaller than
what we find in this study with home delivery, as-
suming that take-up rates would be lower. The
provision of sachets through local health centers may
also lead to selective take-up, potentially to the disad-
vantage of anemic children most in need of
intervention.
This study makes important contributions to the
evidence base on the use of MNPs to address micro-
nutrient deficiency among children. The main
strength of the study is that it is an effectiveness
trial designed to mimic the effects of a government
program. Most existing studies of home fortification
programs have employed weekly or biweekly visits
from researchers to a tightly controlled researcher-
implemented environment [55–58], an approach
which would be costly to implement at scale. In our
study, we delivered the NurtureMate every 6 months
to the households, and left households alone to re-
sume their regular routines.
This study also employed a more extensive data col-
lection effort than previous trials. First, we evaluate
effects on both anemia and measures of cognitive de-
velopment. The three rounds of follow-up surveys at
6 month intervals also allow us to investigate how
impacts of MNPs evolve over time. We are aware of
only two other studies of micronutrient powders that
collected as many rounds of follow-up information
[53, 54].
Despite these strengths, our study does have several
limitations. First, the observed attrition rate was rela-
tively high: 28% of sample children were missing from
at least one of the three survey rounds. Overall, how-
ever, 97% of the sample was followed-up at least
once, which is high compared to previous studies. At-
trition rates were similar between the treatment and
control groups (as shown in Table 7 in Appendix),
but results could have been affected if mechanisms
driving attrition differed across groups. We find no
evidence of this and do not believe that our findings
are invalidated by attrition. A second limitation is that we
were unable to conduct information on biomarkers beyond
hemoglobin. Additional indicators of iron status, markers
of inflammation and additional mineral and vitamin bio-
markers would have been desirable. Third, the trial was
conducted in one poor region of western China; results
may not generalize to other settings. Finally, while we
speculate above, we are unable to say definitively why
MNPs were ineffective at reducing anemia rates as children
aged past 1 year. A priority for future studies should be to
better understand the drivers of anemia in young chil-
dren and how these change as children age.
In sum, our results show that MNPs (using the for-
mulation of China’s proposed national program) did
not improve anemia or cognitive outcomes of chil-
dren after 18 months of age. Although anemia rates
appear to fall quickly as children age, they remained
high at 2 years of age. Such results suggest that the
government might consider raising the level of iron
that is allowed in MNP supplements. More alarming
is the high level of cognitive delay among 2 year olds.
Given that the national program to distribute MNPs
is unlikely to address high levels of cognitive delay
among children, there is an urgent need for effective
strategies to promote the development of young chil-
dren in China’s rural areas. Without effective inter-
ventions, a large fraction of China’s children will be
prevented from reaching their full potential.
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Appendix
Table 6 Effects of multiple micronutrient powder provision on heamoglobin (Hb) concentration, anaemia prevalence, and Bayley
mental and psychomotor development scores by experimental assignment in first period
Hb concentration (g/L)1 Anemia prevalence
(Hb <110 g/L)1
Bayley MDI (points)2 Bayley PDI (points)2
Trial arms compared Difference
(95% CI)
P value Marginal effect
(95% CI)
P- value Difference (95%
CI)
P- value Marginal effect
(95% CI)
P- value
Free vs control after 6 months
follow-up3
1.840
(− 0.189–3.868)
0.075 − 0.048
(− 0.129–0.034)
0.252 3.025
(0.443–5. 606)
0.022* − 1.624
(− 5.166–1.918)
0.368
Free vs control after 12 months3 − 0.502
(− 2.760–1.757)
0.662 0.026
(− 0.056–0.108)
0.535 1.978
(− 0.899–4.855)
0.177 − 0.846
(− 3.807–2.114)
0.574
Free vs control after 18 months3 − 0.718
(− 2.930–1.494)
0.524 0.026
(− 0.054–0.107)
0.523 2.808
(− 0.159–5.774)
0.064 − 0.162
(− 2.785–2.419)
0.902
Text vs control after 6 months4 1.715
(− 0.347–3.777)
0.103 − 0.069
(− 0.146–0.007)
0.075 1.423
(− 1.184–4.030)
0.284 1.061 (− 2.379–
4.501)
0.544
Text vs control after 12 months 4 0.266
(− 2.220–2.752)
0.833 0.042
(− 0.046–0.129)
0.348 − 0.70
(− 3.788–2.389)
0.656 − 0.062
(− 2.886–2.763)
0.966
Text vs control after 18 months 4 0.936
(−1.419–3.290)
0.435 − 0.027
(− 0.110–0.056)
0.526 − 0.776
(− 3.90–2.348)
0.626 0.347
(− 2.600–3.294)
0.817
R-squared 0.14 0.10 0.27 0.21
Observations 6092 6092 6204 6186
1 Intention to treat analysis, and regression estimates from multiple linear models adjusted for gender, age, Hb test machine and county fixed effects. Standard
errors are clustered at the village level
2 Intention to treat analysis, and regression estimates from multiple linear models adjusted for gender, age, parenting practice (whether caregiver used toys
played with child the previous day, sang to child previous day), BSID tester and county fixed effects. Standard errors are clustered at the village level
3 “Free” group received free MNP sachets but not daily text message reminders
4 “Text” group received free MNP sachets and daily text message reminders for the first six months of the trial
*p-value < 0.05 significant
Table 7 Comparison of attrition across MNP and control groups (N = 1802)
Dependent Variable: Lost to follow up at least once (yes = 1, no = 0) 1
Trial arms compared Difference (95% CI) P value
MNP vs control 0.018 (− 0.026–0.063) 0.412
R-squared 0.03
Observations 1802
1Regression estimates from multiple linear models adjusted for county fixed effects. Standard errors are clustered at the village level
Table 8 The average number sachets consumed monthly in MNP group
Intervention time Free MNP Groupa
Average number of sachets consumed monthly
First 6 months intervention 15.73 ± 12.1
Between month 7 and 12 of intervention 14.1 ± 11.0
Between month 13 and 18 of intervention 12.9 ± 11.6
Average 14.3 ± 11.6
Data are presented as mean ± SD
aMNP = Multiple micronutrient powders
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Table 9 Effects of multiple micronutrient powder provision on Bayley mental and psychomotor development delay
Mental delay (MDI < 80)1 Psychomotor delay (PDI < 80)1
Marginal Effect (95% CI) P value Marginal Effect (95% CI) P value
Effect of MNP distribution after 6 months (children 12–18 months of age) − 0.037 (− 0.087–0.013) 0.147 0.000 (− 0.061–0.062) 0.995
Effect of MNP distribution after 12 months − 0.049 (− 0.109–0.011) 0.111 0.025 (− 0.025–0.075) 0.715
Effect of MNP distribution after 18 months − 0.019 (− 0.081–0.042) 0.533 0.015 (− 0.036–0.066) 0.944
R-squared 0.23 0.13
Observations 6204 6186
1 Intention to treat analysis, and regression estimates from multiple linear models adjusted for gender, age, parenting practice (whether caregiver used toys
played with child the previous day, sang to child previous day), BSID tester and county fixed effects. Standard errors are clustered at the village level. MDI data
missing for 214 observations (5 in baseline, 101, 88 and 20 in 6 months, 12 months and 18 months follow-up), and PDI data missing for 233 children (7 in baseline,
102, 98 and 26 in 6 months, 12 months and 18 months follow-up)
Table 10 Dose–response effects of multiple micronutrient powder provision on Bayley mental and psychomotor development
delay
Mental delay (MDI < 80)1 Psychomotor delay (PDI < 80)1
Marginal Effect (95% CI) P value Marginal Effect (95% CI) P value
Effect of MNP distribution after 6 months (children 12–18 months of age) − 0.000 (− 0.001–0.0002) 0.146 − 0.000 (− 0.000–0.000) 0.936
Effect of MNP distribution after 12 months − 0.001 (− 0.001–0.000) 0.101 0.000 (− 0.00–0.00) 0.323
Effect of MNP distribution after 18 months − 0.000 (− 0.001–0.000) 0.396 0.00 (− 0.001–0.001) 0.667
R-squared 0.23 0.12
Observations 6204 6186
1 Intention to treat analysis, and regression estimates from multiple linear models adjusted for gender, age, parenting practice (whether caregiver used toys
played with child the previous day, sang to child previous day), BSID tester and county fixed effects. Standard errors are clustered at the village level. MDI data
missing for 214 observations (5 in baseline, 101, 88 and 20 in 6 months, 12 months and 18 months follow-up), and PDI data missing for 233 children (7 in baseline,
102, 98 and 26 in 6 months, 12 months and 18 months follow-up)
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